Clinical Trial Update: Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for an IBSR program in BRCA1/2 mutation carriers with hereditary breast and ovarian cancer syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Breast and Ovarian Cancer Syndrome

Snippet

Sponsor: Sheba Medical Center | Conditions: Hereditary Breast and Ovarian Cancer Syndrome | Phase 3 | Status: UNKNOWN